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Virulent strains of Newcastle disease virus ([NDV] also known as avian paramyxovirus type 1) can be
discriminated from low-virulence strains by the presence of multiple basic amino acid residues at the proteo-
lytic cleavage site of the fusion (F) protein. However, some NDV variants isolated from pigeons (pigeon
paramyxovirus type 1 [PPMV-1]) have low levels of virulence, despite the fact that their F protein cleavage sites
contain a multibasic amino acid sequence and have the same functionality as that of virulent strains. To
determine the molecular basis of this discrepancy, we examined the role of the internal proteins in NDV
virulence. Using reverse genetics, the genes encoding the nucleoprotein (NP), phosphoprotein (P), matrix
protein (M), and large polymerase protein (L) were exchanged between the nonvirulent PPMV-1 strain AV324
and the highly virulent NDV strain Herts. Recombinant viruses were evaluated for their pathogenicities and
replication levels in day-old chickens, and viral genome replication and plaque sizes were examined in cell
culture monolayers. We also tested the contributions of the individual NP, P, and L proteins to the activity of
the viral replication complex in an in vitro replication assay. The results showed that the replication proteins
of Herts are more active than those of AV324 and that the activity of the viral replication complex is directly
related to virulence. Although the M protein affected viral replication in vitro, it had only a minor effect on
virulence.
Newcastle disease is a severe infectious disease of birds
caused by Newcastle disease virus (NDV), or avian paramyxo-
virus type 1 (APMV-1). NDV is classified in the genus Avula-
virus of the family Paramyxoviridae (32) and has a single-
stranded, negative-sense RNA genome consisting of six genes
in the order 3-NP-P-M-F-HN-L-5 (28) that encode at least
seven proteins: the nucleocapsid protein (NP), the phospho-
protein (P), the matrix protein (M), the fusion protein (F), the
hemagglutinin-neuraminidase protein (HN), and the polymer-
ase protein (L). During P gene transcription, an additional,
nonstructural protein (V) is produced by means of mRNA
editing (55).
The M, F, and HN proteins are associated with the viral
envelope. The F and HN proteins mediate entry and release,
and the M protein is involved in the morphogenesis and bud-
ding of NDV (28). The V protein is involved in interferon
antagonism (42). The NP protein encapsidates the RNA ge-
nome to form the nucleocapsid, which serves as the template
for viral transcription and replication. The P protein is essen-
tial for viral RNA synthesis and has multiple roles (10, 12). It
forms separate complexes with the NP and L proteins and the
nucleocapsid (22). Transcription of the viral genomic RNA
occurs by way of the viral polymerase (P-L complex); the cat-
alytic activities of the polymerase are functions of the L pro-
tein, and the P protein is responsible for the binding of the P-L
complex to the nucleocapsid. Once sufficient viral proteins are
generated, NP starts to bind to the leader chain, a process in
which the P protein acts as a chaperone to deliver NP to the
nascent RNA (11). The NP-P complex is believed to regulate
the switch from transcription to replication (59), but several
findings also show an important role for the M protein in this
process. Because the M protein associates with the nucleocap-
sid (19, 29, 56), it may also affect transcription and/or replica-
tion (17, 19, 25, 38). The P-L complex is responsible for ge-
nome replication, i.e., the synthesis of full-length plus-strand
antigenomic RNA, which in turn serves as the template for the
synthesis of minus-strand genomic RNA, which is ultimately
packaged into progeny virions. The L protein performs post-
transcriptional modification activities such as capping, methyl-
ation, and polyadenylation of mRNAs (47, 53). The NP, P, and
L proteins together constitute the viral replication complex
(28).
Based on the mean times in which they kill inoculated
chicken embryos and their virulences for day-old chickens,
NDV strains can be categorized into one of four pathotypes,
i.e., nonvirulent, lentogenic (low virulence), mesogenic (inter-
mediate), or velogenic (highly virulent) (3). Cleavage of the F
protein is required for the initiation of infection and is the
major virulence determinant. The cleavage site of the F protein
of virulent NDV strains contains multiple basic amino acid
residues and is recognized by ubiquitous intracellular furin-like
proteases, resulting in a systemic infection. The cleavage site of
the F protein of low-virulence strains does not contain these
multiple basic amino acids and is recognized by extracellular
trypsin-like proteases found in a limited number of tissues,
predominantly in the respiratory and intestinal tracts (36, 37),
thereby limiting the replication of low-virulence strains to
these tissues.
Pigeon paramyxovirus type 1 (PPMV-1) strains are variant
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strains of NDV associated with infections of pigeons. Some
PPMV-1 strains behave as lentogenic viruses, i.e., they show a
low intracerebral pathogenicity index (ICPI) in chickens, de-
spite the presence of an F protein cleavage site motif that is
generally associated with virulent viruses (34). In a previous
study, we showed that the exchange of the F gene between a
low-virulence PPMV-1 virus and a highly virulent virus did not
significantly affect the virulences of the chimeric viruses rela-
tive to those of their respective parental viruses (16). Thus, the
low virulence of some PPMV-1 strains must be determined by
other factors. The V, HN, and L proteins of NDV have all been
shown to be involved in the virulence of NDV (14, 23, 24, 33,
41, 42, 50, 51). However, little is still known about the mech-
anisms underlying their function as virulence determinants in
NDV strains and especially in PPMV-1 strains.
In this study, we examined the contributions of the NP, P, M,
and L proteins to the virulence of NDV. Using reverse genet-
ics, the genes encoding these internal proteins were exchanged
between the low-virulence PPMV-1 strain AV324 and the
highly virulent NDV strain Herts. The pathogenicities and
levels of in vivo replication of the chimeric viruses were deter-
mined in 1-day-old chickens. Furthermore, we investigated the
replication kinetics and plaque sizes of the different chimeric
viruses in cell culture monolayers, and we developed an in vitro
replication assay using cotransfection of plasmids encoding a
minigenome that expresses luciferase in the presence of the
NP, P, and L proteins. Our results indicate that the virulence
of NDV is directly related to the activity of the viral replication
complex.
MATERIALS AND METHODS
Cells, viruses, and animals. QM5 cells (4) were grown in QT35 medium
(Gibco-BRL/Life Technologies), and DF-1 cells were grown in Dulbecco’s mod-
ified Eagle’s medium (DMEM) plus GlutaMAX (Invitrogen). Both media were
supplemented with 5% fetal bovine serum and 1% of an antibiotic stock con-
sisting of penicillin (100 units/ml), streptomycin (100 g/ml), and fungizone (2.5
g/ml). Both cell lines were grown at 37°C in a 5% CO2 incubator. The fowlpox
recombinant virus fpE-FLT7pol (6) (hereafter called FPV-T7), which expresses
the bacteriophage T7 RNA polymerase, was used as recently described (15). The
cDNA clone rgAV324 was derived from the low-virulence PPMV-1 strain
AV324/96, and the cDNA clone FL-Herts was derived from the virulent NDV
strain Herts/33, as previously described (14, 16). In this study, specific-pathogen-
free (SPF) chickens were used. Animal experiments were approved by the Ethics
Committee for Animal Experiments of the Central Veterinary Institute of
Wageningen UR and comply with Dutch law on animal experiments.
Construction of full-length chimeric AV324/Herts antigenomic cDNAs. Chi-
meric viruses in which either the individual NP, P, M, or L genes, or combina-
tions thereof, were exchanged between the AV324 and Herts strains were gen-
erated (Fig. 1). The published nucleotide sequences of the Herts/33 (GenBank
accession no. AY741404) and AV324/96 (GenBank accession no. GQ429292)
strains were used as guides for the construction of the chimeric viruses.
To swap the replication genes between the plasmids FL-Herts and rgAV324,
the unique restriction sites SfiI, PacI, AscI, SpeI, and SgfI were used (Fig. 1). To
introduce a unique restriction site for SpeI (position 8101) in the rgAV324AF
cDNA (16), site-directed mutagenesis was performed, resulting in rgAV324AFS.
The superscript AF represents the introduced restriction sites AscI and FseI, and
the superscript AFS represents the introduced restriction sites AscI, FseI, and
SpeI. Plasmids FL-HertsAF and rgAV324AFS were digested with SgfI and PacI to
simultaneously exchange the NP and P genes, resulting in rgAV324(NP-P)Herts
and FL-Herts(NP-P)AV324. Because the PacI site is positioned at nucleotide (nt)
2900 in Herts and nt 2906 in AV324, 57 amino acids of the C terminus of the P
proteins were not exchanged. Of these 57 amino acids, 7 differ between the two
viruses. To exchange the L gene, both full-length cDNA clones were digested
with SpeI and SgfI and reciprocally cloned, resulting in rgAV324(L)Herts and
FL-Herts(L)AV324. The PacI and SpeI sites were used to simultaneously ex-
change the NP, P, and L genes, resulting in rgAV324(NP-P-L)Herts and FL-
Herts(NP-P-L)AV324. To exchange the NP and P genes individually, site-di-
rected mutagenesis was performed to introduce a unique SfiI site in FL-HertsAF
(this site is present in AV324 but is lacking in Herts). To exchange the NP gene,
the SgfI and SfiI sites were used, resulting in rgAV324(NP)Herts and FL-
Herts(NP)AV324, and to exchange the P gene, the SfiI and PacI sites were used,
resulting in rgAV324(P)Herts and FL-Herts(P)AV324. Finally, the M genes were
exchanged, using the PacI and AscI sites, resulting in rgAV324(M)Herts and
FL-Herts(M)AV324.
FIG. 1. Schematic illustration of the cloning strategy used to exchange the NP, P, M, and L genes between FL-HertsAF and rgAV324AFS. The
virulences of the different recombinant viruses were determined by measuring the intracerebral pathogenicity index (ICPI) in day-old chickens. The
maximum ICPI score was 2.0. KM, kanamycin resistance gene positioned in the vector plasmid.
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Rescue of virus from cDNA. QM5 cells were infected with FPV-T7 for 1 h and
subsequently cotransfected with full-length cDNA constructs and helper plas-
mids expressing P and L, as previously described (16, 45). The respective helper
plasmids of either rgAV324 or FL-Herts were used along with their respective
full-length cDNAs to prevent potential heterologous recombination in the trans-
fected cells. After 3 days, the culture supernatant was harvested and inoculated
into 9- to 11-day-old embryonated SPF eggs to obtain a virus stock.
Pathogenicity test, HI assay, and reisolation of virus. Determination of the
intracerebral pathogenicity index (ICPI) in 1-day-old chickens and the hemag-
glutination inhibition (HI) assay were performed as described in European
Council Directive 92/66/EEC (9). Sera of the chickens that survived the ICPI test
were tested in an HI assay to verify that the animals had been infected. In order
to check the sequences of the different recombinant viruses after the ICPI tests,
brains, livers, and lungs of dead chickens were collected, and virus reisolation in
embryonated SPF eggs was performed as previously described (13).
RNA isolation, reverse transcriptase PCR, and sequencing. RNA of the re-
combinant viruses was isolated, using a High Pure viral RNA kit (Roche Diag-
nostics). First-strand DNA synthesis was carried out using a SuperScript III
reverse transcriptase kit (Invitrogen), and PCR fragments were purified using a
High Pure PCR purification kit (Roche Diagnostics). Nucleotide sequencing
(primer sequences are available upon request) was carried out using a BigDye
Terminator v1.1 cycle sequencing kit and a 3130 genetic analyzer instrument
(Applied Biosystems).
Virus quantitation in organs of infected day-old chickens. To compare the
replication kinetics of the NP-P-L chimeric and parental viruses in chickens, 15
1-day-old SPF chicks were intracerebrally inoculated with a 2  103 50% tissue
culture infective dose (TCID50) of virus per chicken. Three birds were sacrificed
daily until 5 days postinfection (pi). Brains, spleens, livers, and lungs were
collected and homogenized in phosphate-buffered saline (PBS), and the virus
titers were determined on QM5 cells, using 10-fold serial dilutions of the cleared
homogenates. Average virus titers were calculated, using the Reed and Muench
method (48), and are expressed as log10 TCID50 per gram of tissue. The dotted
lines in Fig. 2 indicate the virus detection limits in QM5 cells. Because undiluted
homogenized tissue samples were toxic for the cells, these “QM5-negative”
samples were tested for the presence of virus by inoculating undiluted tissue
homogenates into embryonated SPF eggs. Open symbols indicate that inoculated
eggs remained virus negative, whereas closed symbols indicate that inoculated
eggs had become virus positive (Fig. 2).
For statistical analysis, a nonparametric approach based on rank numbers was
used, because the numbers of animals were modest and some observations fall
below the detection limit. Tests over time were performed, and the group in-
fected with virus A was compared with the group infected with virus B by
employing the Wilcoxon rank sum test (the Mann-Whitney test) (8). Per time
point, observations were replaced by ranks. The sum of the ranks over time for
the group infected with virus A was used as a test statistic, large or small values
being critical. The distribution under the null hypothesis of no difference be-
tween both infected groups of the test statistic was obtained by simulation, by
randomly reshuffling the data over the groups. A 0.05 significance level was used.
All calculations were performed with GenStat software (44).
Replication assay. A synthetic DNA containing the T7 RNA polymerase
promoter and the Gaussia luciferase (GLuc) gene (in an antisense orientation)
flanked at the 5 side by the trailer region (AV324, nt 14999 to 15192, or Herts,
nt 14993 to 15186) and at the 3 side by the leader region (AV324 or Herts, nt
1 to 121), followed by the hepatitis delta virus ribozyme and the transcription
termination signal from bacteriophage T7, was synthesized (GenScript Corpo-
ration) and cloned between the LguI and BamHI sites of transcription plasmid
pOLTV5 (45), resulting in the minigenome plasmids designated pAV324-GLuc
and pHerts-GLuc. The sizes of the minigenomes complied with the rule of six
(46). Transcription of plasmid pAV324-GLuc or pHerts-GLuc using T7 RNA
polymerase gives rise to genomic (negative-sense) RNA, as has been described
previously (46).
QM5 cells were infected with FPV-T7 at a multiplicity of infection (MOI) of
FIG. 2. Viral titers of parental and NP-P-L chimeric viruses in different organs after intracerebral inoculation of 1-day-old chickens. Each day,
three chickens were sacrificed, and brains, spleens, livers, and lungs were collected. Virus titers were determined using QM5 cells and are presented
as the average mean virus titers (log10TCID50/g tissue). The dotted lines indicate the detection limits of the virus detection assay in QM5 cells.
“QM5-negative” samples were additionally tested for the presence of virus by inoculating embryonated eggs. Open symbols indicate that inoculated
eggs remained virus negative, and closed symbols indicate that inoculated eggs became virus positive. Because three FL-Herts-infected chickens
died 3 days postinfection, there are only four time points for this group. Error bars show standard deviations.
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1 for 1 h and subsequently cotransfected with either pAV324-GLuc or pHerts-
GLuc and helper plasmids expressing NP, P, and L originating either from the
AV324 strain (16) or from the Herts strain (14). The minigenome and its
expression plasmids containing NP, P, and L were cotransfected at a ratio of
1.0:1.6:0.8:0.8, respectively, by using FuGENE HD (Roche). For normalization,
a plasmid containing the firefly luciferase gene under the control of the human
cytomegalovirus (hCMV) immediate-early promoter (a kind gift of Erik de Vries
and Xander de Haan, Faculty of Veterinary Medicine, Utrecht, Netherlands)
was cotransfected. After 24 h, the expression levels of the secreted (Gaussia) and
internal (firefly) luciferase activities were measured, using a luciferase assay kit
(Promega) and a GloMax luminometer (Promega). One experiment comprises a
triplicate measurement of luciferase expression. A total of six separate experi-
ments were performed. Differences in luciferase expression were statistically
analyzed using the Wilcoxon test. Mean differences were considered significant
when the P value was less than 0.05.
Analysis of genome replication by quantitation of negative-sense genomic
RNA. To investigate the onset and kinetics of virus replication, the relative
amounts of negative-sense genomic RNA were determined by quantitative real-
time reverse transcriptase PCR (qRRT-PCR) at different time points pi. To
set up a qRRT-PCR, the sequences of Herts and AV324 were aligned, using
the EMBL-EBI web-based software ClustalW2 (http://www.ebi.ac.uk/Tools
/clustalw2/index.html). A PCR primer pair was selected in a homologous region
of the L genes such that the primers had no mismatches in either virus. The
sequence of the forward primer is 5-CCCGACCGACTGTGATCTAT-3, and
that of the reverse primer is 5-GCAGCAAGTTGGATTGCAG-3. Subse-
quently, a perfectly matching probe within the same region was chosen and
labeled at the 5 end with 6-carboxyfluorescein (FAM) and at the 3 end with
BHQ1, as follows: 5-FAM-TGCTAGAGGGGGCATTGAGGGA-BHQ1-3
(Tib Mobiol).
DF-1 cells were seeded in 24-well plates (Greiner) and infected in duplicate
with virus at an MOI of 10. At 2, 4, 6, 8, and 10 h pi (hpi), plates were frozen at
70°C. RNA was extracted from the combined infected cells and the superna-
tants, using a MagNA Pure LC total nucleic acid isolation kit and a MagNA Pure
LC instrument (Roche Applied Science) according to the manufacturer’s instruc-
tions. Cycling conditions for the qRRT-PCR, using the Mx3005P system (Strat-
agene), were one cycle at 50°C for 30 min, one cycle at 95°C for 15 min, 45 cycles
at 95°C for 15 s, 55°C for 30 s, and 72°C for 30 s. For data analysis, MxPro qPCR
software, version 4.10 (Stratagene), was used. The correlation coefficients (R2) of
the standard curves were 0.999 (FL-Herts) and 0.993 (rgAV324). All PCR
amplification efficiencies (E) were 0.95. Details of the PCR protocol are avail-
able upon request.
Determination of plaque size. Monolayers of QM5 cells and DF-1 cells were
infected with the parental and chimeric viruses and incubated for 2 days under
an overlay of the Glasgow modification of Eagle medium/Eagle’s minimal es-
sential medium (ASG-Lelystad) containing 1% methylcellulose, without the ad-
dition of exogenous trypsin. Plaques were visualized by immunological staining,
using monoclonal antibody (MAb) Fusie 133 8E12A8C3 (CVI of Wageningen
UR) against the NDV F protein and horseradish peroxidase (HRPO)-conju-
gated polyclonal rabbit anti-mouse Ig (Dako). The average plaque size was
determined by measuring the areas of digital images of 12 to 16 discrete plaques
per virus (photographed at a magnification of 6.3) using Image-Pro Plus software
(MediaCybernetics, Inc.). Differences in plaque size were statistically analyzed
using the Wilcoxon test. Mean differences were considered significant when the
P value was less than 0.05.
RESULTS
Construction and recovery of recombinant viruses. To study
the molecular basis of the low pathogenicities of PPMV-1
strains that contain a fully functional multiple basic amino acid
motif in their F protein cleavage sites, we exchanged the genes
encoding the internal viral proteins NP, P, M, and L between
the nonvirulent PPMV-1 strain AV324 and the highly virulent
NDV strain Herts. The amino acid sequence identity of these
proteins is 94% for NP, 84% for P, 93% for M, and 95% for L.
The cloning strategy that was used to construct the chimeric
cDNAs is described in the Materials and Methods section and
is illustrated in Fig. 1. Sequence analysis of the chimeric
cDNAs confirmed the intended gene exchanges and the ab-
sence of any undesired mutations. For virus recovery by means
of cotransfection, helper plasmids expressing P and L of either
rgAV324 or FL-Herts were used along with their respective
full-length cDNAs. All chimeric viruses could be rescued, in-
dicating that the biological functions of these proteins of the
Herts and AV324 strains are compatible.
Pathogenicity in day-old chickens. The virulences of the
chimeric viruses were assessed by a standard intracerebral
pathogenicity test (ICPI) in 1-day-old chickens. Replacement
of the internal genes of the Herts strain, either individually or
in combination, by those of the AV324 strain resulted in a
decrease in virulence. The simultaneous replacement of the
genes encoding the complete NP-P-L replication complex had
a significant effect on virulence, as shown by a decrease in the
ICPI value from 1.54 for FL-Herts to 0.55 for FL-Herts(NP-
P-L)AV324 (Fig. 1). In contrast, although not all replacements
of the internal genes of AV324 by those of Herts resulted in an
increase in virulence, again the simultaneous replacement of
the NP, P, and L genes had a large effect. The exchange
resulted in a significant increase in ICPI values from 0.10 for
rgAV324 to 1.03 for rgAV324(NP-P-L)Herts (Fig. 1). These
results show that the origin of the complete replication com-
plex from either AV324 or Herts has a major effect on deter-
mining the virulence of the chimeric viruses.
In vivo replication in day-old chickens. Because exchanging
the complete viral replication complex had the greatest effect
on virulence, the levels of in vivo replication of these chimeric
viruses and their parental viruses were determined in day-old
chickens after intracerebral inoculation (Fig. 2). The results
showed that the AV324 strain replicated to much lower levels
than the Herts strain in all organs examined. In brain tissue, no
significant difference in the replication levels of the AV324
recombinant virus that expresses the replication complex of the
Herts strain [rgAV324(NP-P-L)Herts] and that of the parental
AV324 strain was observed (P  0.05). However, in liver,
lungs, and spleen, replication of rgAV324(NP-P-L)Herts was
significantly enhanced compared to that of rgAV324. Con-
versely, providing the Herts virus with the AV324 replication
complex [FL-Herts(NP-P-L)AV324] significantly reduced the
replicative abilities of the chimeric virus in all tissues examined
(Fig. 2). These results strongly suggest that the pathogenicity of
avian paramyxoviruses is directly correlated with the level of
virus replication in organs of infected animals.
In vitro replication assay. To test whether in vivo virus rep-
lication correlated with the intrinsic activity of the viral repli-
cation complex, we developed an in vitro replication assay,
using a minigenome that expresses the Gaussia luciferase
(GLuc) gene in the presence of the NP, P, and L proteins. Two
slightly different minigenomes were used, one based on the
leader and trailer sequences of the Herts strain (pHerts-GLuc)
and the other on the leader and trailer sequences of the AV324
strain (pAV324-GLuc). Transcription of pAV324-GLuc or
pHerts-GLuc using T7 RNA polymerase generates genomic
(negative-sense) minigenome RNA. Hence, expression of the
GLuc gene is dependent on the conversion of the negative-
sense RNA into positive-sense RNA. This process is com-
pletely dependent on the viral NP, P, and L proteins, providing
a suitable assay to test the roles of the individual proteins in
minigenome replication activity.
The in vitro replication assay revealed that the two minige-
nomes behaved similarly, exhibiting comparable levels of re-
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porter gene expression when driven by both the AV324 repli-
cation proteins and those of the Herts virus (data not shown).
This indicates that the nucleotide differences in the leader and
trailer sequences that code for the genomic (3-nt difference)
and antigenomic (4-nt difference) promoter (31) of AV324 and
Herts did not affect the efficiency of viral replication. There-
fore, only the results obtained with the pHerts-GLuc minige-
nome are shown. The results revealed that the activity of the
AV324 replication complex is significantly lower than that of
the Herts replication complex (Fig. 3). Furthermore, none of
the possible combinations of the NP, P, and L proteins
of AV324 and Herts reached the 100% level obtained with the
Herts replication proteins only. These observations suggest
that optimal replication is not determined by one or two pro-
teins but by the combined action of all three replication pro-
teins.
Viral genome replication. To investigate the onset and ki-
netics of viral genome replication of the recombinant viruses in
cell culture monolayers, a qRRT-PCR that specifically detects
negative-strand viral RNA was used. To this end, DF-1 cells
were infected at an MOI of 10, and at different time points up
to 10 hpi, the amount of genomic RNA was determined. The
results showed that the genome of FL-Herts replicated at a
higher rate than that of rgAV324 (Fig. 4). When the Herts
virus was provided with the AV324 replication complex, the
replication kinetics were similar to those of rgAV324. Unex-
pectedly, however, the recombinant virus in which the replica-
tion genes of AV324 were replaced by those of Herts
[rgAV324(NP-P-L)Herts] showed the lowest replication effi-
ciency of all viruses tested. Because several studies have shown
that the M protein may affect transcription and/or replication,
we also examined the recombinant viruses in which only the M
gene was exchanged. The results showed that the kinetics of
FL-Herts(M)AV324 were very similar to those of rgAV324(NP-
P-L)Herts (Fig. 4), suggesting that the specific combination of
the M protein of AV324 and the NP-P-L complex of Herts
results in a decreased replication rate. This effect also seems to
affect virulence, since the introduction of the AV324 M protein
in Herts resulted in a reduction of the ICPI value from 1.54 to
1.18 (Fig. 1). The kinetics of genome replication of rgAV324 was
not increased by the M protein of Herts, and no significant effect on
virulence was noted [cf. rgAV324 and rgAV324(M)Herts], indicating
that the effect is nonreciprocal.
Plaque size. In order to examine the replication of the dif-
ferent viruses in tissue culture cells in another way, we deter-
mined their plaque sizes in monolayers of quail-derived QM5
cells and chicken-derived DF-1 cells at 48 hpi (Fig. 5). Relative
to FL-Herts, rgAV324 showed a significantly smaller plaque
size in QM5 and in DF-1 cells. Furthermore, smaller plaque
sizes in both cell types were also observed when the Herts virus
was provided with the M protein of AV324 or the replication
complex of AV324. When the AV324 virus expressed the M
protein or the replication complex of Herts, QM5 cells and
DF-1 cells showed contrasting results with regard to plaque
size. While the plaque sizes were smaller in QM5 cells, larger
plaques were observed in DF-1 cells (Fig. 5).
DISCUSSION
The results of this study show that all three proteins that
make up the viral replication complex (NP, P, and L) play a
significant role in determining the virulence of NDV. By ex-
changing the replication genes simultaneously, the virulent
Herts virus was significantly attenuated, whereas the low-viru-
lence AV324 strain became much more virulent. All individual
replication proteins have their own contribution but act syner-
gistically when all three together are exchanged. The matrix
(M) protein of AV324 showed a distinct effect on virulence in
the Herts background, probably by interacting with the viral
replication complex. However, this effect was not reciprocal,
since the M protein of Herts lacked the ability to increase the
virulence of AV324.
The difference in virulence between AV324 and Herts seems
to be directly related to the efficiency of in vivo viral replica-
FIG. 3. Relative luciferase expression levels after cotransfection of
FPV-T7-infected QM5 cells with the viral minigenome plasmid (con-
taining the leader and trailer sequences of Herts that flank the Gluc
reporter gene) and plasmids expressing NP, P, and L of Herts (gray) or
AV324 (black). The background level of luciferase activity was deter-
mined by omitting the L plasmid (X). The graph shows the average
values obtained in six separate experiments. On the left y axis, values
for luciferase activities relative to Herts are given, and on the right y
axis, values for luciferase activities relative to AV324 are shown. Error
bars represents standard errors of the means (SEMs).
FIG. 4. Onset and kinetics of negative-sense genomic RNA repli-
cation in the first 10 h of infection. DF-1 cells were infected at an MOI
of 10, and replication was determined by qRRT-PCR. Results are
averages for duplicate infections.
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tion. After the genes encoding the entire NP-P-L replication
complex were exchanged, the virus titers of the virulent Herts
strain in day-old chickens were decreased in all organs exam-
ined, whereas those of the avirulent AV324 strain were in-
creased in three of the four organs tested (Fig. 2). Lentogenic
NDV strains are generally unable to spread systemically when
inoculated intracerebrally. Because these viruses lack the
multibasic cleavage motif in their F proteins, activation re-
quires trypsin-like proteases that are apparently not present in
neuronal tissue. Furthermore, replication of these viruses is
often limited to the inoculation site (39, 51, 60). The titers of
the AV324 strain in brain tissue gradually decreased over time,
but the virus was still able to spread to secondary organs (Fig.
2). However, this systemic infection did not sicken its host
drastically, as evidenced by the virus’s ICPI of 0.10 (Fig. 1) and
the absence of clinical signs (data not shown). Thus, low-
virulence PPMV-1 isolates may be perfectly adapted to their
hosts by being able to spread systemically due to their typical
velogenic F cleavage site motif while replicating at a relatively
low level.
The differences in efficiencies of the viral replication com-
plexes were confirmed in an in vitro replication assay (Fig. 3).
Optimal replication was observed when all three replication
proteins originated from the Herts strain. This finding matches
the results of the ICPI tests (Fig. 1). However, none of the
possible combinations of the NP, P, and L proteins of AV324
and Herts reached the level of replication obtained with only
Herts replication proteins. One of the possible explanations
may be that the individual Herts replication proteins are in-
herently more active but that optimal activity is dependent on
the presence of the cognate interaction partners. The amino
acid sequences of the protein domains responsible for the
interaction of the NP and P proteins (26) differ between Herts
and AV324. Furthermore, although not well identified for
NDV, the interaction domains responsible for the P-L inter-
action presumably also differ between the two viruses, as they
have been shown to differ among several other paramyxovi-
ruses (20, 22, 27, 43, 58). Since these complexes are essential
for transcription and replication of the viral genome (28), they
probably do not function optimally in a heterologous constitu-
tion.
The discrepancy between the in vivo results (Fig. 1 and 2)
FIG. 5. Relative plaque sizes of the recombinant viruses in QM5 (a) and DF-1 (b) cells 48 h postinfection. Plaques were visualized by
immunological staining using a MAb against the NDV F protein. The average plaque size was determined by measuring the areas of at least 12
plaques per virus with Image-Pro Plus software (Media Cybernetics, Inc.). On the left y axis, plaque sizes relative to those of FL-Herts are given,
and on the right y axis, plaque sizes relative to those of rgAV324 are shown. Error bars represent standard deviations.
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and the in vitro results (Fig. 4 and 5) might be explained by the
role of the M protein. While the M protein is considered to be
the central organizer of viral morphogenesis (28), several stud-
ies have shown that in addition, it is involved in regulating viral
RNA synthesis (19, 25, 49). With NP as its most likely binding
partner (25, 40), the M protein associates with the nucleocap-
sid (19, 29, 56). Upon viral entry into the target cell, the
nucleocapsid dissociates from the M protein and is released
into the cytoplasm, where transcription can occur. The inter-
action of the M protein with the nucleocapsid might affect
transcription and have a subsequent effect on replication. Fur-
thermore, this interaction may be strain specific and nonrecip-
rocal and might explain the relatively low replication rate (Fig.
4) and small plaque size (Fig. 5) of rgAV324(NP-P-L)Herts,
since similar results were found for FL-Herts(M)AV324. An-
other possible explanation for our results is that the association
of the M protein with host cell factors might differ between the
two strains. During the infection cycle, the M protein of NDV
and other paramyxoviruses traffics between the cytoplasm and
the nucleus (21). Early during infection, the M protein resides
primarily in the nucleus, while later during infection M is
localized mainly in the cytoplasm (7, 21). It has been suggested
that the function of M in the nucleus relates to inhibition of
host cell functions (1, 18), although this has not yet been
confirmed for NDV. The nuclear localization signals (7) and
the proposed viral late-domain core sequence necessary for
budding, 24FPIV27 (52), do not differ between Herts and
AV324 M proteins.
The involvement of the NP, P, and L proteins in NDV
virulence has been examined before (51). In that study, chi-
meric viruses were generated by exchanging genes between the
lentogenic strain LaSota and the mesogenic strain Beaudette
C, both classified as members of lineage 2 or genotype II in the
avian paramyxovirus type 1 group (2). Surprisingly, a recom-
binant Beaudette C virus that contained the L gene of LaSota
replicated at a higher level and was more virulent than its
parental virus. However, no effect was found for the NP and P
proteins. These results differ from our findings, which show
that all three replication proteins are associated with virulence.
An explanation for this difference might be that LaSota and
Beaudette C belong to the same phylogenetic lineage and
genotype, whereas the strains used in this study belong to
different lineages and genotypes. Herts is classified as a mem-
ber of lineage 3b (or genotype IV), and AV324 belongs to
lineage 4b (or genotype VI) (2). Furthermore, Herts is a chicken-
derived strain, and AV324 is of pigeon origin.
The molecular mechanism for the relationship between the
level of replication of a virus and its pathogenesis is not fully
understood. It is conceivable that higher levels of RNA syn-
thesis lead to higher levels of viral replication and thus to more
virus production. This may overwhelm the host immune re-
sponse, causing enhanced pathogenesis. A correlation between
virulence and the efficiency of viral replication has been ob-
served before. It has, for instance, been reported that reduced
levels of RNA synthesis are associated with reduced virulence
of NDV (30). For several other paramyxoviruses, such as mea-
sles virus (5, 57), respiratory syncytial virus, and parainfluenza
virus (35, 54), it has been described that determinants of virus
attenuation are associated with mutations in the P and L genes.
Due to the use of the PacI cloning site, the exchange of the
P genes actually resulted in the exchange of chimeric P pro-
teins in which 7 of the C-terminal 57 amino acids that differ
between the P proteins of Herts and AV324 are still similar to
those of the backbone strain. Exchanging the chimeric P genes
had only a limited effect on virulence [ICPI  1.33 for FL-
Herts(P)AV324 and ICPI  0.25 for rgAV324(P)Herts]. How-
ever, we cannot completely exclude the possibility that ex-
changing the complete P protein may have had a different
effect on its function and virulence.
In conclusion, this study shows that in addition to the F, V,
HN, and L proteins, the NP, P, and L protein complex con-
tributes to the virulence of NDV. Additional studies will be
required to elucidate whether the proteins have an effect on
viral transcription, replication, or both. Altogether, these ob-
servations illustrate that the virulence of NDV is a complex
trait determined by multiple genetic factors. Furthermore, the
degree to which these factors are involved in NDV virulence
seems to be strain and cell type dependent.
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